Carbubarb

Carbubarb

Clinical data
Trade names	Nogexan
Other names	Carbubarbital
ATC code	none
Identifiers
IUPAC name 2-(5-butyl-2,4,6-trioxo-1,3-diazinan-5-yl)ethyl carbamate
CAS Number	960-05-4^Y
PubChem CID	13743
ChemSpider	13148^Y
UNII	SIW4YR11ST
ChEMBL	ChEMBL2104020^N
CompTox Dashboard (EPA)	DTXSID70242076
Chemical and physical data
Formula	C11H17N3O5
Molar mass	271.273 g·mol^−1
3D model (JSmol)	Interactive image
SMILES CCCCC1(C(=O)NC(=O)NC1=O)CCOC(=O)N
InChI InChI=1S/C11H17N3O5/c1-2-3-4-11(5-6-19-9(12)17)7(15)13-10(18)14-8(11)16/h2-6H2,1H3,(H2,12,17)(H2,13,14,15,16,18)^Y Key:ZWGPHQZXAPWKOV-UHFFFAOYSA-N^Y
^NY (what is this?)  (verify)

Carbubarb (carbubarbital, trade name Nogexan) is a carbamate-substituted barbiturate derivative, which has sedative effects.^[1]

References

1. US patent 4428887, Tou, J. S. & Schleppnik, A. A., "Method of producing mono-substituted terminal diesters", issued 1984-01-31, assigned to Monsanto